95 related articles for article (PubMed ID: 15266011)
21. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.
Fleck BA; Chen C; Yang W; Huntley R; Markison S; Nickolls SA; Foster AC; Hoare SR
Biochemistry; 2005 Nov; 44(44):14494-508. PubMed ID: 16262250
[TBL] [Abstract][Full Text] [Related]
22. The function of the amino terminal domain in NMDA receptor modulation.
Huggins DJ; Grant GH
J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
Conti P; De Amici M; Grazioso G; Roda G; Pinto A; Hansen KB; Nielsen B; Madsen U; Bräuner-Osborne H; Egebjerg J; Vestri V; Pellegrini-Giampietro DE; Sibille P; Acher FC; De Micheli C
J Med Chem; 2005 Oct; 48(20):6315-25. PubMed ID: 16190758
[TBL] [Abstract][Full Text] [Related]
24. Amino acids outside of the loops that define the agonist binding site are important for ligand binding to insect nicotinic acetylcholine receptors.
Liu Z; Han Z; Liu S; Zhang Y; Song F; Yao X; Gu J
J Neurochem; 2008 Jul; 106(1):224-30. PubMed ID: 18363827
[TBL] [Abstract][Full Text] [Related]
25. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
26. Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
Horak M; Vlcek K; Chodounska H; Vyklicky L
Neuroscience; 2006; 137(1):93-102. PubMed ID: 16257494
[TBL] [Abstract][Full Text] [Related]
27. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
Peng JY; Vaidehi N; Hall SE; Goddard WA
ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
[TBL] [Abstract][Full Text] [Related]
28. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
Hansen KB; Tajima N; Risgaard R; Perszyk RE; Jørgensen L; Vance KM; Ogden KK; Clausen RP; Furukawa H; Traynelis SF
Mol Pharmacol; 2013 Jul; 84(1):114-27. PubMed ID: 23625947
[TBL] [Abstract][Full Text] [Related]
29. Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method.
Thomas CG; Krupp JJ; Bagley EE; Bauzon R; Heinemann SF; Vissel B; Westbrook GL
Mol Pharmacol; 2006 Apr; 69(4):1296-303. PubMed ID: 16377766
[TBL] [Abstract][Full Text] [Related]
30. Putative NMDA receptors in Hydra: a biochemical and functional study.
Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
[TBL] [Abstract][Full Text] [Related]
31. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
Speranskiy K; Kurnikova M
Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C enhances glycine-insensitive desensitization of NMDA receptors independently of previously identified protein kinase C sites.
Jackson MF; Konarski JZ; Weerapura M; Czerwinski W; MacDonald JF
J Neurochem; 2006 Mar; 96(6):1509-18. PubMed ID: 16417568
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
Furukawa H; Gouaux E
EMBO J; 2003 Jun; 22(12):2873-85. PubMed ID: 12805203
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
35. MTSEA prevents ligand binding to the human melanocortin-4 receptor by modification of cysteine 130 in transmembrane helix 3.
Cox A; Donnelly D; Kaur M; Cheetham SC; Cockcroft VB; Findlay JB
FEBS Lett; 2005 Jan; 579(1):285-91. PubMed ID: 15620728
[TBL] [Abstract][Full Text] [Related]
36. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
37. The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening.
Jones KS; VanDongen HM; VanDongen AM
J Neurosci; 2002 Mar; 22(6):2044-53. PubMed ID: 11896144
[TBL] [Abstract][Full Text] [Related]
38. Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain.
Stroebel D; Carvalho S; Paoletti P
Neuropharmacology; 2011 Jan; 60(1):151-8. PubMed ID: 20621105
[TBL] [Abstract][Full Text] [Related]
39. A mutation in the glycine binding pocket of the N-methyl-D-aspartate receptor NR1 subunit alters agonist efficacy.
Wood MW; VanDongen HM; VanDongen AM
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):189-92. PubMed ID: 10581413
[TBL] [Abstract][Full Text] [Related]
40. Structural dynamics of the glycine-binding domain of the N-methyl-D-aspartate receptor.
Dolino DM; Cooper D; Ramaswamy S; Jaurich H; Landes CF; Jayaraman V
J Biol Chem; 2015 Jan; 290(2):797-804. PubMed ID: 25404733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
